Corsair Capital Management, L.P. Harrow Health, Inc. Transaction History

Corsair Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.03 - $22.08 $98 - $154	-7 Reduced 0.05%	15,170 $217,000
Q1 2023 May 12, 2023	SELL	$13.84 - $21.46 $173,332 - $268,765	-12,524 Reduced 45.21%	15,177 $321,000
Q4 2022 Feb 13, 2023	SELL	$10.28 - $14.78 $914 - $1,315	-89 Reduced 0.32%	27,701 $408,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $182,580 - $691,415	27,790 New	27,790 $335,000

178

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $926M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Corsair Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Corsair Capital Management, L.P. with notifications on news.